Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB vs EMAPALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELRANATAMAB vs EMAPALUMAB: Safety Overview

Metric ELRANATAMAB EMAPALUMAB
Total FAERS Reports 758 173
Deaths Reported 177 63
Death Rate 23.4% 36.4%
Hospitalizations 482 84
Average Patient Age 67.6 yrs 17.1 yrs
% Female Patients 45.2% 48.7%
Manufacturer Pfizer Laboratories Div Pfizer Inc Swedish Orphan Biovitrum AB (publ)
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription N/A